Intas Pharmaceuticals
Krishna Napit is an experienced professional in the pharmaceutical industry, currently serving as a Research Scientist (Assistant Manager) at Intas Pharmaceuticals since June 2019, where responsibilities include roles in PDL, QMS, and documentation as a Senior Research Associate. Prior experience includes positions at Wockhardt Ltd. as a Research Scientist in R&D QA Formulation TT, Zydus Hospira Oncology Pvt. Ltd. as an IPQA Executive, and Claris Lifesciences as an IPQA Officer. Krishna Napit holds a Master of Science (M.Sc.) in Organic Chemistry from MP Bhoj University Bhopal and a Diploma in Pharmacy from RGPV Bhopal.
This person is not in the org chart
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.